164 related articles for article (PubMed ID: 19459858)
1. Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue.
Hirata E; Arakawa Y; Shirahata M; Yamaguchi M; Kishi Y; Okada T; Takahashi JA; Matsuda M; Hashimoto N
Cancer Sci; 2009 Aug; 100(8):1451-9. PubMed ID: 19459858
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
3. Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Nagai R; Kudo C; Sasada M; Kodama H; Fukai F
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261783
[TBL] [Abstract][Full Text] [Related]
4. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact and functional aspects of tenascin-C expression during glioma progression.
Herold-Mende C; Mueller MM; Bonsanto MM; Schmitt HP; Kunze S; Steiner HH
Int J Cancer; 2002 Mar; 98(3):362-9. PubMed ID: 11920587
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
[TBL] [Abstract][Full Text] [Related]
7. Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.
Iyoda T; Fujita M; Fukai F
Front Immunol; 2020; 11():610096. PubMed ID: 33362799
[TBL] [Abstract][Full Text] [Related]
8. Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Sasada M; Nagai R; Kudo C; Otsuka K; Kamiya S; Kodama H; Fukai F
Mol Cancer Ther; 2019 Sep; 18(9):1649-1658. PubMed ID: 31189613
[TBL] [Abstract][Full Text] [Related]
9. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
12. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
Sarkar S; Zemp FJ; Senger D; Robbins SM; Yong VW
Neuro Oncol; 2015 Aug; 17(8):1095-105. PubMed ID: 25646025
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
14. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
15. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
[TBL] [Abstract][Full Text] [Related]
16. Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.
Ou-Yang Q; He X; Yang A; Li B; Xu M
Cell Physiol Biochem; 2018; 49(6):2382-2395. PubMed ID: 30261490
[TBL] [Abstract][Full Text] [Related]
17. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
18. Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.
Miroshnikova YA; Mouw JK; Barnes JM; Pickup MW; Lakins JN; Kim Y; Lobo K; Persson AI; Reis GF; McKnight TR; Holland EC; Phillips JJ; Weaver VM
Nat Cell Biol; 2016 Dec; 18(12):1336-1345. PubMed ID: 27820599
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.
Wu ZB; Cai L; Lin SJ; Xiong ZK; Lu JL; Mao Y; Yao Y; Zhou LF
Neuro Oncol; 2013 Sep; 15(9):1264-75. PubMed ID: 23828241
[TBL] [Abstract][Full Text] [Related]
20. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]